Skip header and navigation

Refine By

510 records – page 1 of 51.

Abramson: direct-to-consumer advertising will erode health care.

https://arctichealth.org/en/permalink/ahliterature157621
Source
CMAJ. 2008 Apr 22;178(9):1126-7
Publication Type
Article
Date
Apr-22-2008
Author
Ann Silversides
Source
CMAJ. 2008 Apr 22;178(9):1126-7
Date
Apr-22-2008
Language
English
Publication Type
Article
Keywords
Advertising as Topic
Canada
Drug Industry
Drug Prescriptions
Humans
Pharmaceutical Preparations
PubMed ID
18427081 View in PubMed
Less detail

Academia and industry: lessons from the unfortunate events in Toronto.

https://arctichealth.org/en/permalink/ahliterature201078
Source
Lancet. 1999 Mar 6;353(9155):771-2
Publication Type
Article
Date
Mar-6-1999
Author
D G Nathan
D J Weatherall
Author Affiliation
Dana Farber Institute of Cancer Research, Boston, MA, USA.
Source
Lancet. 1999 Mar 6;353(9155):771-2
Date
Mar-6-1999
Language
English
Publication Type
Article
Keywords
Academic Medical Centers - legislation & jurisprudence - trends
Clinical Trials as Topic - legislation & jurisprudence
Drug Industry - legislation & jurisprudence - trends
Humans
Iron Chelating Agents - therapeutic use
Ontario
Pyridones - therapeutic use
Thalassemia - drug therapy
Notes
Comment In: Lancet. 1999 May 29;353(9167):188810359449
PubMed ID
10459956 View in PubMed
Less detail

The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group.

https://arctichealth.org/en/permalink/ahliterature20949
Source
Semin Oncol. 1999 Jun;26(3 Suppl 8):4-8
Publication Type
Article
Date
Jun-1999
Author
J M Nabholtz
M A Lindsay
J. Hugh
J. Mackey
M. Smylie
H J Au
K. Tonkin
M. Allen
Author Affiliation
Northern Alberta Breast Cancer Program, Cross Cancer Institute, Edmonton, Canada.
Source
Semin Oncol. 1999 Jun;26(3 Suppl 8):4-8
Date
Jun-1999
Language
English
Publication Type
Article
Keywords
Academic Medical Centers
Antineoplastic Agents - therapeutic use
Breast Neoplasms - drug therapy
Clinical Trials
Drug Industry
Humans
Interprofessional Relations
Medical Oncology - trends
Research
Research Support, Non-U.S. Gov't
Abstract
In contrast to previous decades, the 1990s have witnessed an increase of new agents with significant activity in breast cancer, including chemotherapy, hormone therapy, and, more recently, biologic modifiers. All information appears to confirm that such a trend will persist and even accelerate in the coming decades. Unless clear strategies of development for new drugs are strictly followed, it will become difficult to adequately assess the many new agents with potentially important activity against breast cancer, and patient access may become a limiting key factor. The academic, global virtual concept is calling for the definition of a new relationship between the pharmaceutical industry and clinical researchers. The main aspect is related to the creation of partnerships with an academically controlled global strategy of development for promising new agents, in which the quality and independence of processes (adjuvant setting, for example) are critical. The means are based on the globalization of patient access (worldwide network) and the virtuality of the approach (modern means of communication as well as access to subgroups of patients). The Breast Cancer International Research Group is the first academic global virtual cooperative group in breast cancer and is making contributions in the development of new drugs, such as taxanes, new antiestrogens, and new cytokines.
PubMed ID
10403467 View in PubMed
Less detail

Access to medicines and global health: will Canada lead or flounder?

https://arctichealth.org/en/permalink/ahliterature181912
Source
CMAJ. 2004 Jan 20;170(2):224-6
Publication Type
Article
Date
Jan-20-2004
Author
James Orbinski
Author Affiliation
St. Michael's Hospital, Centre for International Health, University of Toronto, Toronto, Ont. james.orbinski@utoronto.ca
Source
CMAJ. 2004 Jan 20;170(2):224-6
Date
Jan-20-2004
Language
English
Publication Type
Article
Keywords
Canada
Drug Costs
Drug Industry - organization & administration
Drugs, Essential - supply & distribution
Forecasting
Health Policy
Health Services Accessibility
Humans
National health programs - organization & administration
Needs Assessment
Patents as Topic
World Health
Notes
Comment In: CMAJ. 2004 Apr 27;170(9):1374; author reply 1374-515111456
PubMed ID
14734437 View in PubMed
Less detail

Access to pesticide registration data in Canada: who should know?

https://arctichealth.org/en/permalink/ahliterature235569
Source
CMAJ. 1987 Feb 15;136(4):329-32
Publication Type
Article
Date
Feb-15-1987

[Administrative organization and responsibility].

https://arctichealth.org/en/permalink/ahliterature185287
Source
Ugeskr Laeger. 2003 Apr 14;165(16):1641-2
Publication Type
Article
Date
Apr-14-2003
Author
Jannik C Hilsted
Kim Krogsgaard
Author Affiliation
Hospitalsdirektionen, H:S Rigshospitalet, DK-2100 København ø.
Source
Ugeskr Laeger. 2003 Apr 14;165(16):1641-2
Date
Apr-14-2003
Language
Danish
Publication Type
Article
Keywords
Clinical Trials as Topic - economics - legislation & jurisprudence
Denmark
Drug Industry - economics - legislation & jurisprudence - organization & administration
Ethics Committees, Clinical
Hospital Administration
Humans
Physician's Role
Abstract
The paper describes the current organisation of clinical trials in Danish hospitals, with particular emphasis on the relationship between hospitals and the pharmaceutical industry. Legal responsibilities as well as mutual agreements on collaboration and organisation are described and discussed.
PubMed ID
12756816 View in PubMed
Less detail

Adverse drug reaction reporting controversy.

https://arctichealth.org/en/permalink/ahliterature190622
Source
CMAJ. 2002 Apr 2;166(7):884-5
Publication Type
Article
Date
Apr-2-2002
Author
W C Appel
Source
CMAJ. 2002 Apr 2;166(7):884-5
Date
Apr-2-2002
Language
English
Publication Type
Article
Keywords
Adverse Drug Reaction Reporting Systems - standards - trends
Drug Industry
Humans
Mandatory Reporting
National Health Programs - standards - trends
Ontario
Notes
Cites: Can J Clin Pharmacol. 2001 Summer;8(2):84-811493936
Cites: CMAJ. 2001 Nov 13;165(10):1293, 129511760966
Cites: Pharmacoepidemiol Drug Saf. 2001 May;10(3):191-611501330
PubMed ID
11949980 View in PubMed
Less detail
Source
CMAJ. 2011 Jul 12;183(10):1173, 1175
Publication Type
Article
Date
Jul-12-2011
Author
Heikki Savolainen
Source
CMAJ. 2011 Jul 12;183(10):1173, 1175
Date
Jul-12-2011
Language
English
Publication Type
Article
Keywords
Canada
Child
Drug Industry
Drug Information Services
Drug Labeling
Drug Prescriptions
Drug-Related Side Effects and Adverse Reactions
Humans
Off-Label Use - legislation & jurisprudence
Notes
Cites: CMAJ. 2011 Jun 14;183(9):994-521670118
Cites: Comp Biochem Physiol B. 1973 Feb 15;44(2):467-724350882
Comment On: CMAJ. 2011 Jun 14;183(9):994-521670118
PubMed ID
21746831 View in PubMed
Less detail

510 records – page 1 of 51.